Home/Filings/4/0001104659-20-010062
4//SEC Filing

OH ANDREW M. 4

Accession 0001104659-20-010062

CIK 0001709401other

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:48 PM ET

Size

5.2 KB

Accession

0001104659-20-010062

Insider Transaction Report

Form 4
Period: 2020-01-31
OH ANDREW M.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-01-31+165,000165,000 total
    Exercise: $7.80Exp: 2030-01-30Common Stock (165,000 underlying)
Footnotes (1)
  • [F1]25% of this option shall vest on January 31, 2021, then in 12 equal quarterly installments thereafter.

Documents

1 file

Issuer

Rubius Therapeutics, Inc.

CIK 0001709401

Entity typeother

Related Parties

1
  • filerCIK 0001746614

Filing Metadata

Form type
4
Filed
Feb 2, 7:00 PM ET
Accepted
Feb 3, 9:48 PM ET
Size
5.2 KB